White matter edematous change with moderate vascular lesions in pretreated acute stage of leukoencephalopathy with cerebral amyloid angiopathy

A 79‐year‐old man presented with subacute onset of dementia. Brain magnetic resonance imaging revealed leukoencephalopathy in the posterior lobes with presence of microbleeds. Although clinical manifestation suggested a diagnosis of leukoencephalopathy associated with cerebral amyloid angiopathy (CAA), the patient died of sudden rupture of an aneurysm of the thoracic aorta two months after the onset of dementia. Autopsy revealed pathological features of advanced‐stage Alzheimer's disease. Immunohistochemistry for amyloid‐β revealed CAA mainly affecting arteries but not capillaries. Klüver–Barrera staining revealed white matter edema predominantly in the occipital lobes without ischemic changes. Perivascular cuffing was found to be sparse, but there was no evidence of angiitis. Pathological findings suggest that leukoencephalopathy was caused by the disruption of the blood–brain barrier rather than ischemia. Because the present patient died before immunotherapy, his neuropathological findings could reflect the pathomechanism of the acute stage of leukoencephalopathy with CAA.

[1]  A. Fagan,et al.  APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline , 2020, Nature.

[2]  S. Tetsuka,et al.  Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics , 2019, Journal of the Neurological Sciences.

[3]  C. Greene,et al.  Claudin-5: gatekeeper of neurological function , 2019, Fluids and Barriers of the CNS.

[4]  H. Markus,et al.  Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients , 2019, Stroke.

[5]  B. Kleinschmidt-DeMasters,et al.  PRES: Review of Histological Features , 2018, Journal of neuropathology and experimental neurology.

[6]  Paul Edison,et al.  Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease , 2017, Brain : a journal of neurology.

[7]  D. Tang‐Wai,et al.  Clinical Reasoning: A case of subacute cognitive decline in a 76-year-old man , 2016, Neurology.

[8]  M. Frosch,et al.  Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation. , 2016, JAMA neurology.

[9]  J. Mangin,et al.  White Matter Edema at the Early Stage of Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy , 2015, Stroke.

[10]  A. Kakita,et al.  Cerebral amyloid angiopathy‐related leukoencephalopathy: Successful steroid treatment for neurological deficits and subcortical white matter lesions partly involving the cortical gray matter , 2014 .

[11]  K. Jellinger,et al.  Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. , 2014, American journal of neurodegenerative disease.

[12]  À. Rovira,et al.  Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome , 2014, Neuroradiology.

[13]  Jonathan M. Morris,et al.  Aβ-related angiitis , 2013, Neurology.

[14]  Mahlon D. Johnson,et al.  Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease , 2013, Brain pathology.

[15]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[16]  Hitoshi Takahashi,et al.  Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy‐related inflammation , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

[17]  G. Hunder,et al.  Adult primary central nervous system vasculitis , 2012, The Lancet.

[18]  Clifford R. Jack,et al.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.

[19]  B. Synek,et al.  Cerebral amyloid angiopathy related inflammation: three case reports and a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[21]  G. Hunder,et al.  Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. , 2008, Rheumatology.

[22]  S. Love,et al.  Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 2005 .

[23]  J. Krakauer,et al.  Reversible leukoencephalopathy associated with cerebral amyloid angiopathy , 2004, Neurology.

[24]  H. Braak,et al.  Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .

[25]  L R Caplan,et al.  A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.

[26]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.